ライフサイエンスコーパス: nonsignificant

1 n group 3; P values for all comparisons were nonsignificant).

2 rs1625579 allele frequency distribution (p = nonsignificant).

3 d recurrences (1/23 [4%] versus 2/67 [3%]; P=nonsignificant).

4 sed Classification (0.81, 95% CI, 0.74-0.88; nonsignificant).

5 98)], whereas HRs in cis MUFA quintiles were nonsignificant.

6 All meta-analyses were nonsignificant.

7 = .005) and the effect of cigarette use was nonsignificant.

8 malities at follow-up rendered this increase nonsignificant.

9 labor market status interactions) and mainly nonsignificant.

10 specifically were positive but imprecise and nonsignificant.

11 61-1.95), whereas the genetic estimates were nonsignificant.

12 IN3+ (P = 0.0625) lesions were statistically nonsignificant.

13 placebo; P = .06); however, this finding was nonsignificant.

14 % CI 0.65-1.38]) quartiles was statistically nonsignificant.

15 iations between rhinitis and asthma severity nonsignificant.

16 The odds ratios for girls were nonsignificant.

17 Interactions between PF and age were nonsignificant.

18 22; P = .06), but the weighted difference is nonsignificant.

19 ences among profiles of females were largely nonsignificant.

20 The additional effect of PARI was small and nonsignificant.

21 apparent diffusion coefficient was weak and nonsignificant.

22 ined significant, but bleeding events became nonsignificant.

23 L1 genotype on renal allograft survival were nonsignificant.

24 +/-5.7 and 10.3+/-5.2 years, respectively [P=nonsignificant]).

25 with triglyceride concentration-there was a nonsignificant 1.01 mmol/L decrease in triglyceride per

26 the odds ratio of year of resuscitation to a nonsignificant 1.04.

27 control, 251 deaths occurred, representing a nonsignificant 15% lower risk in the active intervention

28 There was a nonsignificant 16.3% increase in monthly yield of CT pul

29 whereas the %T >10 throughout the day was a nonsignificant 22% less after the no-carbohydrate breakf

30 tdiagnosis TV watching was associated with a nonsignificant 25% increase in all-cause mortality risk

31 domly assigned 60,000 IU cholecalciferol had nonsignificant 28% lower risk of having antibiotics pres

32 There was a nonsignificant 3% reduction in the incidence of ESRD (10

33 ent (AHR, 1.29; 95% CI, 1.17 to 1.41), and a nonsignificant 7% increased risk of outpatient psychiatr

34 stment (8.0% vs 6.6%; AOR, 1.00 [0.94-1.06]; nonsignificant absolute difference, -0.01% [-0.37% to 0.

35 This yielded an overall nonsignificant adjusted odds ratio (OR) of 1.3 (95% conf

36 time intensivist physician staffing remained nonsignificant (adjusted odds ratio, 0.90; 95% CI, 0.70-

37 r time, this difference decreased and became nonsignificant after 24 mo.

38 Benefit became nonsignificant after 7.3 hours.

39 dictors, but associations were attenuated or nonsignificant after additional adjustment for inflammat

40 rend=0.007); however, the association became nonsignificant after additional adjustment for VAT volum

41 ations attenuated toward the null and became nonsignificant after adjusting for potential confounders

42 Results remained nonsignificant after adjustment for age, sex, percentage

43 d- versus average-risk participants remained nonsignificant after adjustment for covariates (odds rat

44 fined to those age 18 to 64 years and became nonsignificant after adjustment for differences in insur

45 ation between hsCRP and health status became nonsignificant after adjustment for sociodemographics, c

46 retinal vessel caliber and heart failure was nonsignificant after adjustment for systolic blood press

47 of dental services was attenuated and became nonsignificant after individual adjustment for total hea

48 Yet, these differences were nonsignificant after multiple-testing correction, sugges

49 This association became nonsignificant after trim-and-fill correction for public

50 tion in men; although both associations were nonsignificant among women, no interaction was observed

51 astases had been cleared at other hospitals (nonsignificant and 5%).

52 0 years) rather than age group, results were nonsignificant and concordant for both studies.

53 n fledging mass by sparrowhawk predation was nonsignificant and could not explain selection to recrui

54 Adjusted ORs remained nonsignificant and decreased after controlling for creat

55 hock during their acute hospitalization with nonsignificant and inconsistent trends noted over time i

56 ss risk of death in blacks versus whites was nonsignificant and not affected by adjustment for covari

57 n success (23/26 [89%] versus 67/73 [92%]; P=nonsignificant) and recurrences (1/23 [4%] versus 2/67 [

58 cleotide polymorphism-based heritability was nonsignificant, and no significant genetic correlations

59 Bivariate analysis showed a nonsignificant association between FcgammaR low-affinity

60 ded geographic site, there was an attenuated nonsignificant association between racial composition in

61 unweighted genetic height score, we found a nonsignificant association with risk of AF (per allele,

62 n multivariable-adjusted models, we observed nonsignificant associations among women in the highest v

63 a-analysis from 3 or 4 cohort studies showed nonsignificant associations of myopia with incident nucl

64 ylaxis in high-risk children primarily found nonsignificant associations on prevention of asthma in s

65 Positive but nonsignificant associations were found for PM2.5 in the

66 Larger but nonsignificant associations were observed after further

67 In additive genetic models, we identified nonsignificant associations with AMD for T280M (RR, 0.87

68 osure variables generally showed similar but nonsignificant associations.

69 ween the highest and the lowest quartile was nonsignificant at 1.06 with a 95% confidence interval sp

70 There was a nonsignificant attenuation in the increase in LV end-dia

71 d 90 days of the first prescription were all nonsignificant between cohorts.

72 ctivity were consistent and differences were nonsignificant between groups throughout the study.

73 Parts A and B and was rendered statistically nonsignificant by APOE epsilon4 in both samples (beta =

74 3830 (61.4%) to 4152 (66.6%) compared with a nonsignificant change from 5049 (61.8%) to 5044 (61.7%)

75 Nonsignificant changes in acellular cementum did not app

76 ive, neovascular AMD, EMB is associated with nonsignificant changes in centerpoint thickness and FFA

77 (respectively, 38.6 versus 41.0 months, P = nonsignificant) CONCLUSIONS: NAFLD-HCC is more often det

78 This second analysis showed a positive but nonsignificant correlation between the eCa response and

79 Conversely, there were nonsignificant correlations between 3moPFS and 6moPFS wi

80 We found weakly positive nonsignificant correlations between urine and dust conce

81 atients in the highest risk quintile, with a nonsignificant cost difference of $941 per patient ($537

82 mortality of 4.2% vs 5.8% (P < .001), with a nonsignificant cost difference of -$862 ($33513 vs $3437

83 8%; 95% CI, -12.7% to -2.8%; P = .002) and a nonsignificant decline in stroke (-3.6%; 95% CI, -7.6% t

84 n the United States, Japan, and Spain, and a nonsignificant decrease in Canada.

85 Comparison of outcomes over time showed a nonsignificant decrease in conversions (right: 14 [13%]

86 There was a nonsignificant decrease in diaphragm tetanic force produ

87 f evidence B (30.5% to 39.8%; P = .17) and a nonsignificant decrease in the use of level of evidence

88 onsidering adult males only, while a slower, nonsignificant decrease of 4.4% per year was found for a

89 , 95% confidence interval: 0.28, 0.99) and a nonsignificant decreased risk of Crohn's disease (hazard

90 We observed similar but nonsignificant decreased risks for HPV18 and 31.

91 .35; 95% confidence interval, .15-.84), with nonsignificant decreases in the risk of low birth weight

92 s 19.91 for the secondary intention group, a nonsignificant difference (P = .41).

93 tment is beneficial, despite a statistically nonsignificant difference for the primary outcome, or di

94 ly, a meta-analysis of folic acid revealed a nonsignificant difference from placebo.

95 ceiving alemtuzumab (P = 0.001), there was a nonsignificant difference in antibody-mediated rejection

96 A similar but nonsignificant difference was found for predicting hospi

97 dy T2D score, but prediction improvement was nonsignificant (difference in C-index 0.02, 95% CI -0.08

98 to that of subordinates, with a similar, but nonsignificant, difference in the 10 day group.

99 end point (HR, 0.68; 95% CI, 0.47-1.00) but nonsignificant differences in the rates of bleeding (0.9

100 However, nonsignificant differences were found between the primar

101 Nonsignificant differences were found in unaffected sibl

102 wever, this association became statistically nonsignificant during the second-to-third-month and four

103 A nonsignificant effect of naltrexone on heavy drinking wa

104 Pooled results indicated a nonsignificant effect on body weight (WMD: -0.47 kg; 95%

105 rtilization success with CO2 treatment and a nonsignificant effect.

106 p = .04), and higher insulin (p = .01), with nonsignificant effects for cortisol and glucose.

107 Surprisingly, we observed nonsignificant effects of the fuel addition treatment on

108 Nonsignificant effects on phosphoinositide 3-kinase/Akt

109 According to the extended IA model, PFOA had nonsignificant effects on the toxicity of PBZ while sign

110 ved yield in favorable conditions but showed nonsignificant effects under stress; they were therefore

111 Nonsignificant effects were observed in the expression o

112 ropyl-p-diethoxymethyl phosphoric acid)] had nonsignificant effects.

113 Comparable, but nonsignificant, effects when comparing a small sample of

114 C (p = .022, Cohen's d = 0.95), with smaller nonsignificant elevations in the prefrontal cortex (p =

115 insulin, and C-reactive protein were mainly nonsignificant, especially after accounting for egg cons

116 Increased but nonsignificant estimated risks were also found for women

117 There were no acute allergic reactions or nonsignificant excesses of 6-month mortality (5.7% CsA v

118 t vary significantly by age, and there was a nonsignificant female predominance.

119 The payment-volume elasticity was nonsignificant for 4 of 6 procedures studied: laser trab

120 mean change from baseline over 12 weeks were nonsignificant for Asthma Control Questionnaire symptom

121 he order: Clip > BSAF > BPAF > BAF, and were nonsignificant for BAF.

122 diac cells to CoE is thought to be minor and nonsignificant for coronary formation.

123 75 year, predominating in women, and became nonsignificant for males thereafter.

124 Global disability results were nonsignificant for pre-late life relative to no PTSD (od

125 Results were similar in trend, but nonsignificant, for the fewer centers with 6- to 7-year-

126 uding European introgressed animals, low and nonsignificant genetic differentiation and isolation by

127 gh in five (26%), with mOS of 156 days and a nonsignificant hazard ratio of 0.339 (P = .093).

128 9) as the reference category produced higher nonsignificant hazard ratios (1.05 vs. 0.97 for men and

129 ow-density lipoprotein cholesterol level was nonsignificant (hazard ratio = 1.10; 95% confidence inte

130 e groups had similar percentages of fat (P = nonsignificant); however, alveolar bone loss was signifi

131 The nonsignificant HRs for 1 year or more of thiopurine and

132 interval (CI), 1.01-1.86], with similar but nonsignificant HRs for 6-month persistent infections.

133 Although differences were nonsignificant, IC plus cetuximab seemed to be the least

134 The small, nonsignificant impact of nonparticipation on rates of in

135 33%) or refractory (12 patients, 13%) had a nonsignificant impact on hospital mortality (odds ratio

136 0 [65] vs 319 [147] mL; P < .001) but only a nonsignificant improvement in the overall distribution o

137 In conclusion, the nonsignificant improvement of risk prediction does not s

138 nalysis, but the estimate was attenuated and nonsignificant in adjusted analysis (adjusted hazard rat

139 reductions that were significant in RAC and nonsignificant in LAC.

140 GDR regardless of BMI, RQ, or sex but became nonsignificant in T2DM.

141 ermediate in the ankle and upper leg and was nonsignificant in the arm, indicating a peripheral nerve

142 years (95% uncertainty interval: 599-823), a nonsignificant increase from the 1990 incidence of SP.

143 a tendency toward a larger but statistically nonsignificant increase in apparent diffusion coefficien

144 P = 0.03) in those with a TT genotype, but a nonsignificant increase in composite endpoint risk (haza

145 We observed a nonsignificant increase in estimated monthly drinks in t

146 HR, 0.79; 95% CI, 0.67-0.94; P=0.008) and a nonsignificant increase in hemorrhagic stroke (0.8% vers

147 The nonsignificant increase in incidence and IB mortality in

148 A nonsignificant increase in non-PCV13 serotype OM was obs

149 R + MR results in a nonsignificant increase in PFS compared with R.

150 ion with population density was poor, with a nonsignificant increase in SCAs with population density

151 d CDR cancer detection rate (P = .001) and a nonsignificant increase in sensitivity (P = .15).

152 One trial showed a statistically nonsignificant increase in suicidal ideation with venlaf

153 ticholinergic Drug Scale score resulted in a nonsignificant increase in the probability of delirium o

154 5% CI, 0.39-0.88]; P = .01), and there was a nonsignificant increase in the proportion of appropriate

155 spiration thrombectomy was associated with a nonsignificant increase in the risk of stroke 0.6% versu

156 Numerically, there was a nonsignificant increase in the use of level of evidence

157 ally controlled asthma was associated with a nonsignificant increase of $9.5 (95% CI -$13.6 - $32.6)

158 one HPV vaccination outcome, one reported a nonsignificant increase, and one reported mixed effects.

159 Dechlorane plus showed a nonsignificant increase.

160 Overall, there was a statistically nonsignificant increased risk in long-term (2- to 5-year

161 ratio, 1.75; 95% CI, 1.01-2.98) as well as a nonsignificant increased risk of suspected tendinitis (6

162 The APE was associated with a slight, nonsignificant, increased risk of CRM involvement [odds

163 Some congeners showed nonsignificant increases from sampling round 1 (winter)

164 itude was less than 1 HU, with statistically nonsignificant increases in patient CNR at 100 kVp of 8%

165 of fortified foods (P < 0.001), with further nonsignificant increases in supplement users.

166 per urinary tract cancer revealed slight but nonsignificant increases in the ORs for localized diseas

167 We estimated small, nonsignificant increases in the risk of death from nonca

168 This analysis showed a positive, but nonsignificant interaction effect (95% CI for above-grou

169 tic risk status and LZ intake (P=0.0009) but nonsignificant interactions between genetic risk status

170 he multiple regression analysis, and whether nonsignificant interactions were true or caused by insuf

171 icare payment-service volume elasticity were nonsignificant: intravitreal injection elasticity, -0.75

172 A nonsignificant inverse association was observed between

173 For BPA, we observed a nonsignificant inverse association with total 25(OH)D in

174 0.97) and IHD (0.86; 0.75, 0.97), as well as nonsignificant inverse associations for risk of stroke (

175 For VLCSFAs in erythrocytes, a nonsignificant inverse trend with CHD risk was observed

176 1 year after recurrent MI), but decreased to nonsignificant level beyond 1 month after the bleeding (

177 e=0.42) but were substantially attenuated to nonsignificant levels for other treatments.

178 OR], 1.52; 95% CI, .58-3.98; P = .39), and a nonsignificant lower odds ratio with cefepime use (aOR,

179 Use of the SDA was associated with a nonsignificant lower perinatal mortality of 14 per 1000

180 confidence interval 0.23-0.73; P=0.003), and nonsignificant lower risk of stroke and thromboembolic e

181 ignificant intimal thickening (P=0.05) and a nonsignificant medial thinning (P=0.22) compared with RI

182 , associations were substantially weaker and nonsignificant (moderate smoking during pregnancy: HR, 1

183 alpha1-microglobulin and TFF-3 resulted in a nonsignificant net reclassification index (NRI) of 3% fo

184 odds ratio for recent femoral proportion was nonsignificant (odds ratio, 0.99; 95% confidence interva

185 s controlled for CRP, the effect size became nonsignificant (odds ratio, 1.56; confidence interval, 0

186 parameter combinations and was offset (i.e., nonsignificant) only for dramatic increases in different

187 tralia, Canada, Japan, and Slovakia, despite nonsignificant or significantly decreasing incidence of

188 Nonsignificant ORs of exposure to inhaled beta2-agonists

189 Elevated but nonsignificant ORs were estimated for the highest versus

190 t some biologically meaningful pathways with nonsignificant P-values become statistically significant

191 There was a modest, nonsignificant (p = 0.13) decline in LSGM concentrations

192 es of 104 computed tomography scans showed a nonsignificant (P = 0.23) reduction in yearly rates of c

193 ough the gene-dietary fat interaction became nonsignificant (P = 0.30).

194 ally significant compared with those classed nonsignificant (P<0.001).

195 of large (>500 kb) rare CNVs, we observed a nonsignificant (P=0.271) 1.126-fold enriched rate of sub

196 eduction by PARI beyond the effect of LS was nonsignificant (P=0.60).

197 lues of BMO-MRW tended to have a higher, but nonsignificant, pAUC across all sectors compared with RN

198 ed to expected ratios for the 2 programs was nonsignificant (Pearson product moment correlation, rho

199 eding 1.75 using National Quality Forum, but nonsignificant performance using Acute Physiology and Ch

200 ate HR for black vegans showed a similar but nonsignificant point estimate (HR: 0.69; 95% CI: 0.41, 1

201 ce interval, 1.09-1.79), with a similar, but nonsignificant, point estimate in the first trimester.

202 contrast, Tourette's syndrome had a smaller, nonsignificant polygenic component, predicting only 0.6%

203 By contrast, a nonsignificant positive association was observed between

204 d FFA [SMD=0.86 (95% CI: 0.50, 1.22)], and a nonsignificant positive association with leptin levels [

205 There were nonsignificant positive dose responses for both CLL and

206 A small, nonsignificant positive effect on the Trailmaking A test

207 sample of published RCTs with statistically nonsignificant primary outcome and with spin in the abst

208 ended the intervention of interest despite a nonsignificant primary outcome.

209 In RCTs with statistically nonsignificant primary outcomes published in surgical jo

210 In all, 110 eligible RCTs with nonsignificant primary outcomes were appraised.

211 ), while controls demonstrated statistically nonsignificant progression (baseline, 8.3 [1.6], follow-

212 or these associations were all statistically nonsignificant (range, P = .24 to P = .45).

213 There was a nonsignificant reduced incidence of chest pain with ECG

214 Regarding mortality we observed a nonsignificant reduction associated with NAI treatment (

215 s no significant reduction in death or MI, a nonsignificant reduction in all primary endpoint compone

216 centrations was associated with a modest and nonsignificant reduction in child BMI.

217 Glomerulopenia was associated with a nonsignificant reduction in GFR in the hypertensive grou

218 [41.6%]; RR, 0.77 [95% CI, 0.71-0.83]) and a nonsignificant reduction in hospital, 28-day, or 30-day

219 tration of BCG-Denmark was associated with a nonsignificant reduction in neonatal mortality rate (MRR

220 lls from PhtD-vaccinated adult mice led to a nonsignificant reduction in NP colonization density, whe

221 There was a marginally nonsignificant reduction in syncope in the fludrocortiso

222 es >/=90%, and in this subgroup, there was a nonsignificant reduction in the end point of mortality a

223 There was a nonsignificant reduction in the first event of stroke of

224 on implemented by PCPs provided a modest but nonsignificant reduction in the incidence of major depre

225 ulticlonal infections were associated with a nonsignificant reduction in the risk of malaria in the a

226 ransplant with any bridging therapy showed a nonsignificant reduction in the risk of waitlist dropout

227 erence by v1 was suggested in 2012-2013 with nonsignificant reduction in VE when v1 approximately v2

228 A statistically nonsignificant reduction was seen in the risk of high wa

229 ow to intermediate risk showed statistically nonsignificant reductions in early (OR, 0.67 [CI, 0.42 t

230 Further studies should examine whether the nonsignificant reductions in IgE-associated allergies ar

231 Nonresponders largely showed lesser/nonsignificant reductions in key inflammatory and barrie

232 Full coverage was also associated with nonsignificant reductions in the rate of major vascular

233 tion (OR, 0.56; 95% CI, 0.43-0.73; P<0.001), nonsignificant reductions of stent thrombosis (OR, 0.46;

234 Single adversities tended to have nonsignificant relations with telomere length.

235 intussusception cases (7.11 expected), for a nonsignificant relative risk of 1.1.

236 5% versus 0.2%; p = 0.03) with a similar but nonsignificant response to CFP-10.

237 folic acid, vitamin C, and tryptophan, with nonsignificant results for inositol.

238 controlled trials (RCTs) with statistically nonsignificant results for primary outcomes in surgical

239 a defined search strategy, RCTs with clearly nonsignificant results for the primary outcome (P > 0.05

240 Similar nonsignificant results were found in sensitivity analyse

241 Nonsignificant results were obtained for the last subgro

242 e, or distract the reader from statistically nonsignificant results) in published reports of randomiz

243 predictions, even though both analyses gave nonsignificant results.

244 studies (n = 9) reporting primarily mixed or nonsignificant results.

245 ificant results and D = 0.24 (0.11-0.42) for nonsignificant results.

246 %; 95% CI, 26.6-27.7), with an increased but nonsignificant risk for PSI in 2007 (adjusted odds ratio

247 A statistically nonsignificant risk increase of 0.3% (95% CI: -0.4%, 1.5

248 The cohort study revealed an increased but nonsignificant risk of LTBI among diabetics (risk ratio,

249 n apoB levels and a corresponding attenuated nonsignificant risk of major cardiovascular events (OR,

250 mputation rates was considerably reduced and nonsignificant (RR = 0.78; 95% CI, 0.40-1.51; P = 0.46).

251 lary and mandibular premolars demonstrated a nonsignificant RSA percentage at the evaluated CRRs.

252 FFR flow was higher than iFR flow in nonsignificant stenoses (FFR >0.75; mean FFR flow, 42.3+

253 ologically significant undergo PCI than when nonsignificant stenoses are treated.

254 nd alkali intake, p.E161K SNP carriers had a nonsignificant tendency to higher urinary pH on a random

255 dy was a post hoc analysis and statistically nonsignificant, this trial lends some support to the hyp

256 ercury in Hudson Bay murre eggs changed from nonsignificant to a significantly increasing trend.

257 ght only in the prasugrel group, there was a nonsignificant treatment-by-weight interaction for plate

258 Adjusted models showed a nonsignificant trend between ARAS and reduction in GFR (

259 status in 1-month biopsy samples revealed a nonsignificant trend for higher regulatory T cell freque

260 was 14% greater, and there was a similar but nonsignificant trend for otolith size.

261 nfidence interval [CI], 12-18 months) with a nonsignificant trend in favor of non-PVT versus PVT pati

262 crophages), B cells, and CD8+ T cells, and a nonsignificant trend in the reduction of lung neutrophil

263 T on the HAM-D (beta = -0.88; P = .03) and a nonsignificant trend on the BDI (beta = -1.14; P = .08,

264 degree of carotid stenosis, but there was a nonsignificant trend suggesting a higher risk of adverse

265 and remained stable thereafter; there was a nonsignificant trend toward a flatter posterior KA and s

266 iseconds [95% CI, 0.6-6.2]; P<0.0001), and a nonsignificant trend toward an increase in heart failure

267 lative increase, p = 0.002), and there was a nonsignificant trend toward an increase in P-selectin ex

268 mortality in women with HF, and there was a nonsignificant trend toward an inverse association with

269 The 5-year survival was 73.1+/-2%, with a nonsignificant trend toward better survival in groups A

270 .31; 95% CI: 1.09, 1.58) and a statistically nonsignificant trend toward greater risk of relapse (RR:

271 in the Fe group (P = 0.013), and there was a nonsignificant trend toward higher Bifidobacterium spp.

272 There was a nonsignificant trend toward higher in-hospital stroke (O

273 covery Following Revascularization) showed a nonsignificant trend toward improved outcomes at 1 year

274 There was a nonsignificant trend toward improved sensitivity for dia

275 for LT, the use of LRT is associated with a nonsignificant trend toward improved waitlist and posttr

276 ibit superoxide production associated with a nonsignificant trend toward increased FMDBA in the place

277 stratified by examination times, exhibited a nonsignificant trend toward increased positivity at prol

278 There was a nonsignificant trend toward less worsening in apathy and

279 compared with the placebo group, there was a nonsignificant trend toward lower daily activity (-381 a

280 A nonsignificant trend toward lower disease incidence was

281 There was a nonsignificant trend toward lower microvascular obstruct

282 This pilot trial found a nonsignificant trend toward lower mortality with restric

283 There was a nonsignificant trend toward lower rates of GUSTO-defined

284 Propensity score-matched pairs showed a nonsignificant trend toward lower risk of all-cause deat

285 BG performed between 24 to 72 hours showed a nonsignificant trend toward poorer long-term outcomes.

286 Participants with any CMBs showed a nonsignificant trend toward reduced CBF.

287 ting (P = .005), and nausea (P = .02), and a nonsignificant trend was found for pain (P = .054), refl

288 ompared with clinical (p < .001) or healthy (nonsignificant trend) control subjects.

289 There were nonsignificant trends for larger amygdala and entorhinal

290 Subgroup analyses showed nonsignificant trends in which survival was greater for

291 Erythrocyte VLCSFAs were associated with nonsignificant trends of lower CHD risk.

292 post hoc high-risk subgroup analyses showed nonsignificant trends that seem to be in good agreement

293 Group A showed statistically nonsignificant trends toward improved freedom from pulse

294 ined variables nor were there any consistent nonsignificant trends.

295 A nonsignificant upward trend (P = 0.24) by cumulative exp

296 s significantly lower when compared with FFR nonsignificant vessels (-21 [-27; -16] vs. -11 [-16; -3]

297 Some of the risk factors became nonsignificant when each procedure was examined separate

298 The association became nonsignificant when fully adjusted for NIH funding level

299 w back pain, although this difference became nonsignificant when studies with high risk for bias were

300 the active and placebo groups, respectively (nonsignificant), with no difference in AUC analysis for